Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P McCormack

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Canadian Family Physician Medecin De Famille Canadien|January 22, 2025
Sodium restrictions in heart failureRicky D Turgeon, James P McCormack, Jen Potter
BMJ (Clinical Research Ed.)|June 16, 2016
Guidelines for treating risk factors should include tools for shared decision makingJohn S Yudkin, Jayne Kavanagh, James P McCormack
Diabetes Care|August 22, 2015
Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149James P McCormack, Stephen A Martin, David H Newman
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 14, 2024
British Columbia community pharmacy during COVID-19: Describing the patient experience via Google reviewsPriya Bains, Fong Chan, James P McCormack, et al.
Canadian Family Physician Medecin De Famille Canadien|May 14, 2024
Shared decision-making approach to type 2 diabetes managementBlair J MacDonald, James P McCormack, Ricky D Turgeon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 6, 2010
Is bigger better? An argument for very low starting dosesJames P McCormack, G Michael Allan, Adil S Virani
The New England Journal of Medicine|July 12, 2014
Changes in diabetes-related complications in the United StatesStephen A Martin, James P McCormack, David H Newman
Journal of the American College of Clinical Pharmacy : JACCP|January 12, 2024
The endurance of medication overload: Rethinking the medication review processJames P McCormack, Shannon Brownlee, Judith Garber, et al.
BMJ Open|January 2, 2015
Representations of the health value of vitamin D supplementation in newspapers: media content analysisTimothy Caulfield, Marianne I Clark, James P McCormack, et al.
Plos One|March 1, 2019
Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysisRicky D Turgeon, Michael R Kolber, Peter Loewen, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Canadian Family Physician Medecin De Famille Canadien|January 22, 2025
Sodium restrictions in heart failureRicky D Turgeon, James P McCormack, Jen Potter
BMJ (Clinical Research Ed.)|June 16, 2016
Guidelines for treating risk factors should include tools for shared decision makingJohn S Yudkin, Jayne Kavanagh, James P McCormack
Diabetes Care|August 22, 2015
Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149James P McCormack, Stephen A Martin, David H Newman
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 14, 2024
British Columbia community pharmacy during COVID-19: Describing the patient experience via Google reviewsPriya Bains, Fong Chan, James P McCormack, et al.
Canadian Family Physician Medecin De Famille Canadien|May 14, 2024
Shared decision-making approach to type 2 diabetes managementBlair J MacDonald, James P McCormack, Ricky D Turgeon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 6, 2010
Is bigger better? An argument for very low starting dosesJames P McCormack, G Michael Allan, Adil S Virani
The New England Journal of Medicine|July 12, 2014
Changes in diabetes-related complications in the United StatesStephen A Martin, James P McCormack, David H Newman
Journal of the American College of Clinical Pharmacy : JACCP|January 12, 2024
The endurance of medication overload: Rethinking the medication review processJames P McCormack, Shannon Brownlee, Judith Garber, et al.
BMJ Open|January 2, 2015
Representations of the health value of vitamin D supplementation in newspapers: media content analysisTimothy Caulfield, Marianne I Clark, James P McCormack, et al.
Plos One|March 1, 2019
Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysisRicky D Turgeon, Michael R Kolber, Peter Loewen, et al.
Pageof 4